Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | -10,253 | 3,707 | 2,686 | 7,383 | -10,391 |
| Cost of Goods | -6,846 | 1,798 | 1,605 | 4,073 | -3,876 |
| Gross Profit | -3,407 | 1,909 | 1,081 | 3,310 | -6,515 |
| Operating Expenses | 6,183 | 8,915 | 7,133 | 9,851 | 9,704 |
| Operating Income | -10,436 | -6,208 | -5,447 | -6,468 | -17,095 |
| Other Income | -1,388 | -1,802 | -672 | -877 | -737 |
| Pre-tax Income | -11,824 | -8,010 | -6,119 | -7,345 | -17,832 |
| Net Income Continuous | -11,824 | -8,010 | -6,119 | -7,345 | -17,832 |
| Net Income | $-8,469 | $-8,010 | $-6,119 | $-7,345 | $-10,885 |
| EPS Basic Total Ops | -0.80 | -0.90 | -0.70 | -0.80 | -1.20 |
| EPS Basic Continuous Ops | -1.29 | -0.86 | -0.66 | -0.79 | -1.97 |
| EPS Diluted Total Ops | -0.80 | -0.90 | -0.70 | -0.80 | -1.20 |
| EPS Diluted Continuous Ops | -1.29 | -0.86 | -0.66 | -0.79 | -1.97 |
| EBITDA(a) | $-9,602 | $-5,306 | $-4,536 | $-5,531 | $-16,260 |